Serum transforming growth factor α level as a marker of hepatocellular carcinoma complicating cirrhosis

Cancer

Volumn 77, Issue 6, 1996, Pages 1056-1060

  Tomiya, Tomoaki ^a   Fujiwara, Kenji ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

cirrhosis; enzyme linked immunosorbent assay; hepatocellular carcinoma; transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PREDICTION; PRIORITY JOURNAL;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 0029990077     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960315)77:6<1056::AID-CNCR8>3.0.CO;2-F     Document Type: Article

References (28)

1. Derynck R. Transforming growth factor α. Cell 1988;54:593-5.
2. Massague J. Transforming growth factor-α; a model for membrane-anchored growth factors. J Biol Chem 1990; 265:21393-6.
3. Marquardt H. Hunkapiller MW, Hood LE, Todaro GJ. Rat transforming growth factor type I: Structure and relation to epidermal growth factor. Science 1984;223:1079-82.
4. Todaro GJ, Fryling C, deLarco JE. Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 1980;77:5258-62.
5. DeLarco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 1978; 75:4001-5.
6. Anzano M, Roberts AB, Smith JM, Sporn MB, DeLarco JE. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and type ß transforming growth factors. Proc Natl Acad Sci USA 1983; 80:6264-8.
7. Massague J. Epidermal growth factor-like transforming growth factor. I. Isolation, chemical characterization, and potentiation by other transforming factors from feline sarcoma virus-transformed rat cells. J Biol Chem 1983; 258:13606-13.
8. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, et al. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 1987;47:707-12.
9. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGF α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990;61:1137-46.
10. Lee GH, Merlino G, Fausto N. Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res 1992;52:5162-70.
11. Twardzik DR, Sherwin SA, Ranchalis J, Todaro GJ. Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humans. J Natl Cancer Inst 1982;69:793-98.
12. Sherwin SA, Twardzik DR, Bohn WH, Cockley KD, Todaro GJ. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res 1983;43:403-7.
13. Kimball ES, Bohn WH, Cockley KD, Warren TC, Sherwin SA. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals. Cancer Res 1984;44:3613-9.
14. Yeh YC, Tsai JF, Chuang LY, Yeh HW, Tsai JH, Florine DL, et al. Elevation of transforming growth factor and its relationship to the epidermal growth factor and α-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res 1987;47:896-901.
15. Stromberg K, Hudgins WR, Orth DN. Urinary TGFsI in neoplasia: Immunoreactive TGF-α in the urine of patients with disseminated breast carcinoma. Biochem Biophys Res Commun 1987; 144:1059-68.
16. Gregory H, Thomas CE. Willshire IR, Young JA, Anderson H, Baildam A, et al. Epidermal and transforming growth factor α in patients with breast tumors. Br J Cancer 1989;59:605-9.
17. Yeh J, Yeh YC. Transforming growth factor-α and human cancer Biomed Pharmacother 1989; 43:651-60.
18. Katoh M, Inagaki H, Kurosawa-Ohsawa K, Katsuura M, Tanaka S. Detection of transforming growth factor alpha in human urine and plasma. Biochem Biophys Res Commun 1990; 167:1065-72.
19. Chuang LY, Tsai JH, Yeh YC, Chang CC, Yeh HY, Guh JY, et al. Epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma. Hepatology 1991;13:1112-6.
20. World Health Organization. Advances in viral hepatitis. Report of the WHO Expert Committee on Viral Hepatitis. WHO Tech Res Ser 1977;602:67-47.
21. Luetteke NC, Michalopoulos GK, Teixido J, Gilmore R, Massague J, Lee DC. Characterization of high molecular weight transforming growth factor a produced by rat hepatocellular carcinoma cells. Biochemistry 1988;27:6487-94.
22. Imanishi K, Yamaguchi K, Suzuki M, Honda S, Yanaihara N, Abe K. Production of transforming growth factor-α in human tumor cell lines. Br J Cancer 1989;59:761-5.
23. Conn HO, Atterbury CE. Cirrhosis. In: Schiff L, Schiff ER, editors. Diseases of the liver. 7th ed. Philadelphia: J.B. Lippincott, 1993:875-934.
24. Tomiya T, Fujiwara K. Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immtmosorbent assay. Hepatology 1993; 18:304-8.
25. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986;110:13-20.
26. Inagaki H, Katoh M, Kurokawa-Ohsawa K, Tanaka S. A new sandwich enzyme-linked immunosorbent assay (ELISA) for transforming growth factor a (TGFα) based upon conformational modification by antibody binding. J Immunol Methods 1990;128:27-37.
27. Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 1991;324:933-40.
28. Sato Y, Fujiwara K, Ogata I, Ohta Y, Hayashi S, Oka Y, et al. Transcatheter arterial embolization for hepatocellular carcinoma. Cancer 1985;55:2822-5.